HIV-1 protease-IN-15
HIV-1 protease-IN-15 (Compound 27) is an orally active and selective inhibitor targeting HIV-1 protease with a pIC50 value of 9.347. HIV-1 protease-IN-15 inhibits HIV protein maturation, blocks viral replication. HIV-1 protease-IN-15 is promising for research of HIV-1 infection[1].
Product Specifications
CAS Number
2986573-09-3
UNSPSC
12352005
Target
HIV; HIV Protease
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Field of Research
Infection
Smiles
O=C(N[C@@H](CC1=CC=CC=C1)[C@H](O)CN(CC(C)C)S(C2=CC=C(C(F)(F)F)C=C2)(=O)=O)[C@@H]3CCCNC3
Molecular Formula
C27H36F3N3O4S
Molecular Weight
555.65
References & Citations
[1]Chen J, et al. Rational Design and Multi-tiered Computational Evaluation of Novel Darunavir Derivatives as HIV-1 Protease Inhibitors: an Integrated Approach Using QSAR Model, Molecular Docking, MD Simulations, DFT Analysis, and ADME Profiling. Chem Biodivers. 2025 May 30:e03500.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC742146-500 1x 500 µL
PU.1 (SPI-1) (B-Cell Marker) (PU1/2146), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880015-100 1x 100 µL
CD56 / NCAM (123C3.D5), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742309-500 1x 500 µL
NKX2.2 (Neuroendocrine & Ewing s Sarcoma Marker) (rNX2/1523), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details